FDC Q2 FY27 revenue rises 21%, profit rises 73%; Rs 120 crore buyback approved

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

FDC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.8%Reaction day

₹353.00

prior close

₹385.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 170sector+0.6%+6.2% vs sector

On the reaction day the stock moved 6.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.8

10m

-4.3

15m

-4.2

30m

-3.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.8pendingpending+0.6+6.2

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

FDC reported unaudited consolidated Q2 FY27 revenue of Rs 572.14 crore, up 21% year on year, and profit after tax of Rs 49.06 crore, up 73%. H1 revenue rose 11% to Rs 1,239.83 crore and profit after tax rose 21% to Rs 181.55 crore. Net operating cash flow was Rs 251.26 crore, versus negative Rs 1.94 crore last year. Limited review was unmodified. The Board also approved a buyback of up to 24 lakh shares at Rs 500 each, capped at Rs 120 crore.

Likely market impact

Positive as profit and cash flow improved; the buyback may support shareholder returns. It will use cash, while H1 revenue growth was modest.